| CARLAT PUBLISHING

Buprenorphine Treatment

Buprenorphine is a first line medication for the treatment of opioid use disorder yet remains vastly under-prescribed. Here, Dr. Capurso reviews the pharmacologic principles relevant to buprenorphine prescribing and lays out how to start patients on the medication both in the clinic and at home. Read More

Drug Overdoses in the US: Trends and Prevention Strategies

Increases in drug overdose mortality continues unabated around the country driven by widespread availability of illicit fentanyl and methamphetamines. Dr. Sharfstein provides context to these concerning trends and discusses prevention and harm reduction strategies clinicians can implement for their patients. Read More

Addiction is a major risk factor for suicide. Here, we provide a practical guide to Safety Planning, an evidenced based approach for reducing suicide risk that can be implemented in a variety of clinical settings. Read More

Avoiding buprenorphine induced withdrawal during induction can be particularly tricky for those using fentanyl. Researchers describe a novel induction dosing strategy that mitigates this risk. Read More

Buprenorphine Induction Without Withdrawal

Making the switch from full opioid agonist to buprenorphine usually involves a period of withdrawal prior to starting the medication. Here, researchers describe a method of switching from full to partial opioid agonist by using small “microdoses” in order to avoid withdrawal. Read More

Suboxone vs. Vivitrol for Opioid Use Disorder: How Do you Choose?

Buprenorphine and long acting injectable naltrexone are both effective for the treatment of opioid use disorder; however, until now, we had little data to predict which patients would do better on which medications. Here, researchers identify patient characteristics predictive of success on buprenorphine versus naltrexone. Read More

Psychiatry Practice Boosters, Second Edition (2018)
Teaches you the key points of 42 of the most clinically relevant studies in psychiatry published...
READ MORE

General Psychiatry
Using SAMe In Clinical Practice with Garrett Rossi, MD
Read More

Addiction Treatment
Supervised Drug Consumption Sites
Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.
Listen now